Fundraising Fox

Jill DeSimone

Investor

Digital Pharma Advisor at Excelerate Health Ventures

Sarasota, Florida, United States

About

Former Merck Oncology President and biopharma board director.

Experience

  1. IndegeneFounder and Chair of Strategic Advisory Boardcurrent2023 — presentPrinceton, New Jersey, United States
  2. Praxis Precision Medicines, Inc.Independent Board Directorcurrent2022 — presentBoston, Massachusetts, United States
  3. JM DeSimone ConsultingFounder & Consulting Advisorcurrent2022 — presentSarasota, Florida, United States
  4. iTeos TherapeuticsIndependent Board Director2024 — 2025Waltham, Massachusetts, United States
  5. Affini-T TherapeuticsIndependent Board Director2022 — 2025Watertown, Massachusetts, United States
  6. Oncternal TherapeuticsIndependent Board Director2023 — 2025San Diego, California, United States
  7. Kinnate Biopharma Inc.Independent Board Director2023 — 2024San Francisco/San Diego
  8. MerckFormer President, U.S. Oncology | Established $9BN Leading Oncology Business2014 — 2022Pennsylvania
  9. Teva PharmaceuticalsSVP, Global Women’s Health | Created Teva’s 1st Global Business Unit from Multiple Acquisitions2012 — 2014Frazer, Pennsylvania, United States
  10. Bristol Myers SquibbSVP, U.S. Oncology, growth to over $2BN+ in Annual Revenue2010 — 2012Princeton, New Jersey, United States
  11. Bristol Myers SquibbSVP, U.S. Virology / HIV | Turned HIV Business Around to One of the leading HIV companies2006 — 2010Princeton, New Jersey, United States

Education

  1. Northeastern UniversityBachelor of Science - BS, Pharmacy
  2. The Wharton SchoolFellowship

Skills & more

Pharmaceutical Industry10Oncology12HIV Virology3Cardiology34Transformational Leadership3Executive Team Building3Organization Culture Design3Turnaround Management3Diversity & Inclusion3People Development3Talent Strategy2Fundraising2
+1 moreBoard Recruitment

From Jill's professional profile.

Same school

Shared employers

Colleagues at Excelerate Health Ventures